Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileJessica Haberer, M.D.

TitleAssociate Professor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressMassachusetts General Hospital
Global Health
100 Cambridge St, 15th floor
Boston MA 02114
Phone617/724-0351
Fax617/724-1637
vCardDownload vCard (login for email)

Collapse Mentoring 
Collapse completed student projects
The acceptability and impact of a weekly text-messaging program to support HIV treatment adherence in KwaZulu-Natal, South Africa
International, 06/24/14 - 08/24/14
Assessing the social capital of caregivers for children with HIV in Mbarara, Uganda
International, 06/11/11 - 08/05/11
Factors that motivate otherwise healthy HIV+ young adults to access HIV testing and treatment in Gugulethu, South Africa: A qualitative study
Summer, 06/12/15 - 01/28/16

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
K24MH114732     (HABERER, JESSICA ELIZABETH)Sep 1, 2017 - Aug 31, 2022
NIH/NIMH
Optimizing mHealth for adherence monitoring and intervention
Role: Principal Investigator

R01MH109309     (HABERER, JESSICA ELIZABETH)Jun 22, 2016 - Apr 30, 2020
NIH/NIMH
Next generation real-time monitoring for PrEP adherence in young Kenyan women
Role: Co-Principal Investigator

R21AI108329     (HABERER, JESSICA ELIZABETH)Jun 7, 2013 - May 31, 2015
NIH/NIAID
The ethics of electronic adherence monitoring for HIV research and care in Uganda
Role: Co-Principal Investigator

R01MH098744     (HABERER, JESSICA ELIZABETH)Jun 4, 2013 - May 31, 2018
NIH/NIMH
Real World Adherence to HIV PrEP in Serodiscordant African Couples
Role: Principal Investigator

R34MH100940     (HABERER, JESSICA ELIZABETH)Jun 1, 2013 - May 31, 2016
NIH/NIMH
Development of Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Matthews LT, Burns BF, Bajunirwe F, Kabakyenga J, Bwana M, Ng C, Kastner J, Kembabazi A, Sanyu N, Kusasira A, Haberer JE, Bangsberg DR, Kaida A. Beyond HIV-serodiscordance: Partnership communication dynamics that affect engagement in safer conception care. PLoS One. 2017; 12(9):e0183131. PMID: 28880892.
    View in: PubMed
  2. Garrison LE, Haberer JE. Technological methods to measure adherence to antiretroviral therapy and preexposure prophylaxis. Curr Opin HIV AIDS. 2017 Sep; 12(5):467-474. PMID: 28590335.
    View in: PubMed
  3. Lee GQ, Bangsberg DR, Mo T, Lachowski C, Brumme CJ, Zhang W, Lima VD, Boum Y, Mwebesa BB, Muzoora C, Andia I, Mbalibulha Y, Kembabazi A, Carroll R, Siedner MJ, Haberer JE, Mocello AR, Kigozi SH, Hunt PW, Martin JN, Harrigan PR. Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches. AIDS. 2017 08 21. PMID: 28832407.
    View in: PubMed
  4. Velloza J, Celum C, Haberer JE, Ngure K, Irungu E, Mugo N, Baeten JM, Heffron R. Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda. AIDS Behav. 2017 Aug; 21(8):2509-2518. PMID: 28634661.
    View in: PubMed
  5. Andriesen J, Bull S, Dietrich J, Haberer JE, Van Der Pol B, Voronin Y, Wall KM, Whalen C, Priddy F. Using Digital Technologies in Clinical HIV Research: Real-World Applications and Considerations for Future Work. J Med Internet Res. 2017 Jul 31; 19(7):e274. PMID: 28760729.
    View in: PubMed
  6. Haberer JE, Kidoguchi L, Heffron R, Mugo N, Bukusi E, Katabira E, Asiimwe S, Thomas KK, Celum C, Baeten JM. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence. J Int AIDS Soc. 2017 Jul 25; 20(1):1-9. PMID: 28741331.
    View in: PubMed
  7. Lee GQ, McCluskey S, Boum Y, Hunt PW, Martin JN, Bangsberg DR, Gao X, Harrigan PR, Haberer JE, Siedner MJ. Should abacavir be a first-line alternative for adults with HIV in sub-Saharan Africa? J Acquir Immune Defic Syndr. 2017 Jun 19. PMID: 28639996.
    View in: PubMed
  8. McCluskey SM, Boum Y, Musinguzi N, Haberer JE, Martin JN, Hunt PW, Marconi VC, Bangsberg DR, Siedner MJ. Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure. J Acquir Immune Defic Syndr. 2017 Jun 15. PMID: 28628529.
    View in: PubMed
  9. Mugyenyi GR, Atukunda EC, Ngonzi J, Boatin A, Wylie BJ, Haberer JE. Functionality and acceptability of a wireless fetal heart rate monitoring device in term pregnant women in rural Southwestern Uganda. BMC Pregnancy Childbirth. 2017 Jun 08; 17(1):178. PMID: 28595604.
    View in: PubMed
  10. Thomson KA, Haberer JE, Marzinke MA, Mujugira A, Hendrix CW, Celum C, Ndase P, Ronald A, Bangsberg DR, Baeten JM. Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention. J Acquir Immune Defic Syndr. 2017 Jun 01; 75(2):184-189. PMID: 28291050.
    View in: PubMed
  11. Musinguzi N, Mocello RA, Boum Y, Hunt PW, Martin JN, Haberer JE, Bangsberg DR, Siedner MJ. Duration of Viral Suppression and Risk of Rebound Viremia with First-Line Antiretroviral Therapy in Rural Uganda. AIDS Behav. 2017 Jun; 21(6):1735-1740. PMID: 27256394.
    View in: PubMed
  12. North CM, Valeri L, Hunt PW, Mocello AR, Martin JN, Boum Y, Haberer JE, Bangsberg DR, Christiani DC, Siedner MJ. Cooking fuel and respiratory symptoms among people living with HIV in rural Uganda. ERJ Open Res. 2017 Apr; 3(2). PMID: 28534032.
    View in: PubMed
  13. Mayer KH, Safren SA, Elsesser SA, Psaros C, Tinsley JP, Marzinke M, Clarke W, Hendrix C, Wade Taylor S, Haberer J, Mimiaga MJ. Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of "Life-Steps for PrEP". AIDS Behav. 2017 May; 21(5):1350-1360. PMID: 27848089.
    View in: PubMed
  14. Campbell JI, Aturinda I, Mwesigwa E, Burns B, Santorino D, Haberer JE, Bangsberg DR, Holden RJ, Ware NC, Siedner MJ. The Technology Acceptance Model for Resource-Limited Settings (TAM-RLS): A Novel Framework for Mobile Health Interventions Targeted to Low-Literacy End-Users in Resource-Limited Settings. AIDS Behav. 2017 Apr 18. PMID: 28421356.
    View in: PubMed
  15. Lee S, Byakwaga H, Boum Y, Burdo TH, Williams KC, Lederman MM, Huang Y, Tracy RP, Cao H, Haberer JE, Kembabazi A, Bangsberg DR, Martin JN, Hunt PW. Immunologic Pathways That Predict Mortality in HIV-Infected Ugandans Initiating Antiretroviral Therapy. J Infect Dis. 2017 04 15; 215(8):1270-1274. PMID: 28329310.
    View in: PubMed
  16. Haberer JE, Sabin L, Amico KR, Orrell C, Galárraga O, Tsai AC, Vreeman RC, Wilson I, Sam-Agudu NA, Blaschke TF, Vrijens B, Mellins CA, Remien RH, Weiser SD, Lowenthal E, Stirratt MJ, Sow PS, Thomas B, Ford N, Mills E, Lester R, Nachega JB, Bwana BM, Ssewamala F, Mbuagbaw L, Munderi P, Geng E, Bangsberg DR. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc. 2017 Mar 22; 20(1):1-15. PMID: 28364569.
    View in: PubMed
  17. Haberer JE, Sabin L, Amico KR, Orrell C, Galárraga O, Tsai AC, Vreeman RC, Wilson I, Sam-Agudu NA, Blaschke TF, Vrijens B, Mellins CA, Remien RH, Weiser SD, Lowenthal E, Stirratt MJ, Sow PS, Thomas B, Ford N, Mills E, Lester R, Nachega JB, Bwana BM, Ssewamala F, Mbuagbaw L, Munderi P, Geng E, Bangsberg DR. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc. 2017; 20(1):21371. PMID: 28630651.
    View in: PubMed
  18. Ayakaka I, Ackerman S, Ggita JM, Kajubi P, Dowdy D, Haberer JE, Fair E, Hopewell P, Handley MA, Cattamanchi A, Katamba A, Davis JL. Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach. Implement Sci. 2017 Mar 09; 12(1):33. PMID: 28274245.
    View in: PubMed
  19. Georgette N, Siedner MJ, Petty CR, Zanoni BC, Carpenter S, Haberer JE. Impact of a clinical program using weekly Short Message Service (SMS) on antiretroviral therapy adherence support in South Africa: a retrospective cohort study. BMC Med Inform Decis Mak. 2017 Feb 20; 17(1):18. PMID: 28219372.
    View in: PubMed
  20. Lambert RF, Orrell C, Bangsberg DR, Haberer JE. Factors that Motivated Otherwise Healthy HIV-Positive Young Adults to Access HIV Testing and Treatment in South Africa. AIDS Behav. 2017 Feb 11. PMID: 28190116.
    View in: PubMed
  21. Atukunda EC, Musiimenta A, Musinguzi N, Wyatt MA, Ashaba J, Ware NC, Haberer JE. Understanding Patterns of Social Support and Their Relationship to an ART Adherence Intervention Among Adults in Rural Southwestern Uganda. AIDS Behav. 2017 Feb; 21(2):428-440. PMID: 27671479.
    View in: PubMed
  22. Haberer JE, Musinguzi N, Tsai AC, Boum Y, Bwana BM, Muzoora C, Hunt PW, Martin JN, Bangsberg DR. Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring. AIDS. 2017 Jan 02; 31(1):169-171. PMID: 27835622.
    View in: PubMed
  23. Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, Ongachi S, Sedah E, Okwero E, Ngure K, Odoyo J, Bulya N, Haberer JE, Baeten JM, Heffron R. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention. J Acquir Immune Defic Syndr. 2017 Jan 01; 74 Suppl 1:S15-S22. PMID: 27930607.
    View in: PubMed
  24. Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, Ongachi S, Sedah E, Okwero E, Ngure K, Odoyo J, Bulya N, Haberer JE, Baeten JM, Heffron R. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention. J Acquir Immune Defic Syndr. 2017 Jan 01; 74 Suppl 6:S15-S22. PMID: 27923009.
    View in: PubMed
  25. Madrasi K, Chaturvedula A, Haberer JE, Sale M, Fossler MJ, Bangsberg D, Baeten JM, Celum C, Hendrix CW. Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis. J Clin Pharmacol. 2017 May; 57(5):606-615. PMID: 27922719.
    View in: PubMed
  26. Okello S, Asiimwe SB, Kanyesigye M, Muyindike WR, Boum Y, Mwebesa BB, Haberer JE, Huang Y, Williams K, Burdo TH, Tracy RP, Bangsberg DR, Mocello AR, Martin JN, Hunt PW, Siedner MJ. D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda. J Acquir Immune Defic Syndr. 2016 Dec 01; 73(4):396-402. PMID: 27171743.
    View in: PubMed
  27. Haberer JE. Actionable adherence monitoring to optimise intervention. Lancet HIV. 2017 Jan; 4(1):e5-e6. PMID: 27864001.
    View in: PubMed
  28. Roberts ST, Haberer J, Celum C, Mugo N, Ware NC, Cohen CR, Tappero JW, Kiarie J, Ronald A, Mujugira A, Tumwesigye E, Were E, Irungu E, Baeten JM. Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study. J Acquir Immune Defic Syndr. 2016 Nov 01; 73(3):313-322. PMID: 27243900.
    View in: PubMed
  29. Georgette N, Siedner MJ, Zanoni B, Sibaya T, Petty CR, Carpenter S, Haberer JE. The Acceptability and Perceived Usefulness of a Weekly Clinical SMS Program to Promote HIV Antiretroviral Medication Adherence in KwaZulu-Natal, South Africa. AIDS Behav. 2016 Nov; 20(11):2629-2638. PMID: 26781866.
    View in: PubMed
  30. Musinguzi N, Muwonge T, Thomas K, Baeten JM, Bangsberg DR, Haberer JE. Does Adherence Change When No One is Looking? Comparing Announced and Unannounced Tenofovir Levels in a PrEP Trial. AIDS Behav. 2016 Nov; 20(11):2639-2643. PMID: 26781865.
    View in: PubMed
  31. Zanoni BC, Archary M, Buchan S, Katz IT, Haberer JE. Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave. BMJ Glob Health. 2016 Nov; 1(3):e000004. PMID: 28588949.
    View in: PubMed
  32. Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, Asiimwe S, Haberer JE, Morton J, Ngure K, Bulya N, Odoyo J, Tindimwebwa E, Hendrix C, Marzinke MA, Ware NC, Wyatt MA, Morrison S, Haugen H, Mujugira A, Donnell D, Celum C. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda. PLoS Med. 2016 Aug; 13(8):e1002099. PMID: 27552090; PMCID: PMC4995047.
  33. Lu Y, Goti V, Chaturvedula A, Haberer JE, Fossler MJ, Sale ME, Bangsberg D, Baeten JM, Celum CL, Hendrix CW. Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods. Antimicrob Agents Chemother. 2016 Sep; 60(9):5379-86. PMID: 27353269; PMCID: PMC4997873 [Available on 03/01/17].
  34. Haberer JE, Musiimenta A, Atukunda EC, Musinguzi N, Wyatt MA, Ware NC, Bangsberg DR. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016 May 15; 30(8):1295-300. PMID: 26760452; PMCID: PMC4851578.
  35. Ware NC, Pisarski EE, Tam M, Wyatt MA, Atukunda E, Musiimenta A, Bangsberg DR, Haberer JE. The Meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. AIDS. 2016 May 15; 30(8):1287-94. PMID: 26807967; PMCID: PMC4853242.
  36. Boatin AA, Wylie BJ, Goldfarb I, Azevedo R, Pittel E, Ng C, Haberer JE. Wireless Vital Sign Monitoring in Pregnant Women: A Functionality and Acceptability Study. Telemed J E Health. 2016 Jul; 22(7):564-71. PMID: 27172448.
    View in: PubMed
  37. Musinguzi N, Muganzi CD, Boum Y, Ronald A, Marzinke MA, Hendrix CW, Celum C, Baeten JM, Bangsberg DR, Haberer JE. Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa. AIDS. 2016 Apr 24; 30(7):1121-9. PMID: 26785125.
    View in: PubMed
  38. Matthews LT, Ribaudo HB, Kaida A, Bennett K, Musinguzi N, Siedner MJ, Kabakyenga J, Hunt PW, Martin JN, Boum Y, Haberer JE, Bangsberg DR. HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods. J Acquir Immune Defic Syndr. 2016 Apr 01; 71(4):399-406. PMID: 26495883; PMCID: PMC4943862 [Available on 04/01/17].
  39. Siedner MJ, Kim JH, Nakku RS, Hemphill L, Triant VA, Haberer JE, Martin JN, Boum Y, Kwon DS, Tsai AC, Hunt PW, Okello S, Bangsberg DR. HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda. AIDS. 2016 Feb 20; 30(4):667-70. PMID: 26636926; PMCID: PMC4733585 [Available on 02/20/17].
  40. Haberer JE. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice. Curr Opin HIV AIDS. 2016 Jan; 11(1):10-7. PMID: 26633638; PMCID: PMC4801217 [Available on 01/01/17].
  41. Haberer JE, Musinguzi N, Boum Y, Siedner MJ, Mocello AR, Hunt PW, Martin JN, Bangsberg DR. Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda. J Acquir Immune Defic Syndr. 2015 Dec 01; 70(4):386-92. PMID: 26110445; PMCID: PMC4624495 [Available on 12/01/16].
  42. Campbell JI, Haberer JE. Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances. Curr HIV/AIDS Rep. 2015 Dec; 12(4):523-31. PMID: 26439917.
    View in: PubMed
  43. Campbell JI, Eyal N, Musiimenta A, Haberer JE. Ethical Questions in Medical Electronic Adherence Monitoring. J Gen Intern Med. 2016 Mar; 31(3):338-42. PMID: 26358284; PMCID: PMC4762813 [Available on 03/01/17].
  44. Siedner MJ, Kim JH, Nakku RS, Bibangambah P, Hemphill L, Triant VA, Haberer JE, Martin JN, Mocello AR, Boum Y, Kwon DS, Tracy RP, Burdo T, Huang Y, Cao H, Okello S, Bangsberg DR, Hunt PW. Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy. J Infect Dis. 2016 Feb 01; 213(3):370-8. PMID: 26347573; PMCID: PMC4704672 [Available on 02/01/17].
  45. Sabin LL, Bachman DeSilva M, Gill CJ, Zhong L, Vian T, Xie W, Cheng F, Xu K, Lan G, Haberer JE, Bangsberg DR, Li Y, Lu H, Gifford AL. Improving Adherence to Antiretroviral Therapy With Triggered Real-time Text Message Reminders: The China Adherence Through Technology Study. J Acquir Immune Defic Syndr. 2015 Aug 15; 69(5):551-9. PMID: 25886927; PMCID: PMC4552400 [Available on 08/15/16].
  46. Haberer JE, Bangsberg DR, Baeten JM, Curran K, Koechlin F, Amico KR, Anderson P, Mugo N, Venter F, Goicochea P, Caceres C, O'Reilly K. Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm. AIDS. 2015 Jul 17; 29(11):1277-85. PMID: 26103095; PMCID: PMC4480436.
  47. Siedner MJ, Santorino D, Lankowski AJ, Kanyesigye M, Bwana MB, Haberer JE, Bangsberg DR. A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: a prospective observational cohort study. BMC Med. 2015 Jul 06; 13:160. PMID: 26149722; PMCID: PMC4494725.
  48. Nieves CI, Kaida A, Seage GR, Kabakyenga J, Muyindike W, Boum Y, Mocello AR, Martin JN, Hunt PW, Haberer JE, Bangsberg DR, Matthews LT. The influence of partnership on contraceptive use among HIV-infected women accessing antiretroviral therapy in rural Uganda. Contraception. 2015 Aug; 92(2):152-9. PMID: 25983013; PMCID: PMC4941236.
  49. Kintu A, Hankinson SE, Balasubramanian R, Ertel K, Tumwesigye E, Bangsberg DR, Haberer JE. Sexual Relationships Outside Primary Partnerships and Abstinence Are Associated With Lower Adherence and Adherence Gaps: Data From the Partners PrEP Ancillary Adherence Study. J Acquir Immune Defic Syndr. 2015 May 01; 69(1):36-43. PMID: 25942457; PMCID: PMC4422183.
  50. Petersen ML, LeDell E, Schwab J, Sarovar V, Gross R, Reynolds N, Haberer JE, Goggin K, Golin C, Arnsten J, Rosen MI, Remien RH, Etoori D, Wilson IB, Simoni JM, Erlen JA, van der Laan MJ, Liu H, Bangsberg DR. Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring. J Acquir Immune Defic Syndr. 2015 May 01; 69(1):109-18. PMID: 25942462; PMCID: PMC4421909.
  51. Ware NC, Pisarski EE, Haberer JE, Wyatt MA, Tumwesigye E, Baeten JM, Celum CL, Bangsberg DR. Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study. AIDS Behav. 2015 May; 19(5):811-20. PMID: 25267114; PMCID: PMC4415942.
  52. Mugo PM, Sanders EJ, Mutua G, van der Elst E, Anzala O, Barin B, Bangsberg DR, Priddy FH, Haberer JE. Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya. AIDS Behav. 2015 May; 19(5):794-801. PMID: 25432877; PMCID: PMC4415948.
  53. Kreitchmann R, Coelho DF, Kakehasi FM, Hofer CB, Read JS, Losso M, Haberer JE, Siberry GK, Harris DR, Yu Q. Long-term postpartum adherence to antiretroviral drugs among women in Latin America. Int J STD AIDS. 2016 Apr; 27(5):377-86. PMID: 25931238.
    View in: PubMed
  54. Rana Y, Haberer J, Huang H, Kambugu A, Mukasa B, Thirumurthy H, Wabukala P, Wagner GJ, Linnemayr S. Short message service (SMS)-based intervention to improve treatment adherence among HIV-positive youth in Uganda: focus group findings. PLoS One. 2015; 10(4):e0125187. PMID: 25881059; PMCID: PMC4400100.
  55. Olds PK, Kiwanuka JP, Ware NC, Tsai AC, Haberer JE. Explaining antiretroviral therapy adherence success among HIV-infected children in rural Uganda: a qualitative study. AIDS Behav. 2015 Apr; 19(4):584-93. PMID: 25323679; PMCID: PMC4393764.
  56. Siedner MJ, Santorino D, Haberer JE, Bangsberg DR. Know your audience: predictors of success for a patient-centered texting app to augment linkage to HIV care in rural Uganda. J Med Internet Res. 2015 Mar 24; 17(3):e78. PMID: 25831269; PMCID: PMC4389108.
  57. Boatin AA, Wylie B, Goldfarb I, Azevedo R, Pittel E, Ng C, Haberer J. Wireless fetal heart rate monitoring in inpatient full-term pregnant women: testing functionality and acceptability. PLoS One. 2015; 10(1):e0117043. PMID: 25622043; PMCID: PMC4306498.
  58. Chan BT, Weiser SD, Boum Y, Siedner MJ, Mocello AR, Haberer JE, Hunt PW, Martin JN, Mayer KH, Bangsberg DR, Tsai AC. Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion. AIDS. 2015 Jan 02; 29(1):83-90. PMID: 25268886; PMCID: PMC4286463.
  59. Chan BT, Weiser SD, Boum Y, Haberer JE, Kembabazi A, Hunt PW, Martin JN, Mocello AR, Bangsberg DR, Tsai AC. Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiation. AIDS Behav. 2015 Jan; 19(1):19-26. PMID: 24788780; PMCID: PMC4256126.
  60. Baxi SM, Liu A, Bacchetti P, Mutua G, Sanders EJ, Kibengo FM, Haberer JE, Rooney J, Hendrix CW, Anderson PL, Huang Y, Priddy F, Gandhi M. Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures. J Acquir Immune Defic Syndr. 2015 Jan 01; 68(1):13-20. PMID: 25296098; PMCID: PMC4262724.
  61. Psaros C, Haberer JE, Boum Y, Tsai AC, Martin JN, Hunt PW, Bangsberg DR, Safren SA. The factor structure and presentation of depression among HIV-positive adults in Uganda. AIDS Behav. 2015 Jan; 19(1):27-33. PMID: 24854877; PMCID: PMC4360967 [Available on 01/01/16].
  62. Olds PK, Kiwanuka JP, Nansera D, Huang Y, Bacchetti P, Jin C, Gandhi M, Haberer JE. Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda. AIDS Care. 2015; 27(3):327-32. PMID: 25483955; PMCID: PMC4305465.
  63. Kaida A, Matthews LT, Ashaba S, Tsai AC, Kanters S, Robak M, Psaros C, Kabakyenga J, Boum Y, Haberer JE, Martin JN, Hunt PW, Bangsberg DR. Depression during pregnancy and the postpartum among HIV-infected women on antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr. 2014 Dec 01; 67 Suppl 4:S179-87. PMID: 25436816; PMCID: PMC4251908.
  64. Bajunirwe F, Haberer JE, Boum Y, Hunt P, Mocello R, Martin JN, Bangsberg DR, Hahn JA. Comparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda. PLoS One. 2014; 9(12):e113152. PMID: 25436894; PMCID: PMC4249861.
  65. Atwiine B, Kiwanuka J, Musinguzi N, Atwine D, Haberer JE. Understanding the role of age in HIV disclosure rates and patterns for HIV-infected children in southwestern Uganda. AIDS Care. 2015; 27(4):424-30. PMID: 25397994.
    View in: PubMed
  66. Baeten JM, Donnell D, Mugo NR, Ndase P, Thomas KK, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kidoguchi L, Coombs RW, Hendrix C, Marzinke MA, Frenkel L, Haberer JE, Bangsberg D, Celum C. Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. Lancet Infect Dis. 2014 Nov; 14(11):1055-1064. PMID: 25300863; PMCID: PMC4252589.
  67. Heffron R, Celum C, Mugo N, Katabira E, Bukusi E, Asiimwe S, Ngure K, Bulya N, Odoyo J, Tindimwebwa E, Donnell D, Haberer JE, Kidoguchi L, Morton J, Baeten JM. High Initiation and Adherence among High Risk African HIV Discordant Couples in a Demonstration Project of PrEP and ART for HIV Prevention. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A71-2. PMID: 25357925.
    View in: PubMed
  68. Mayer KH, Safren S, Haberer J, Elsesser S, Clarke W, Hendrix CW, Marzinke M, Mimiaga MJ. Project PrEPARE: High Levels of Medication Adherence with Continued Condomless Sex in U.S. Men who Have Sex with Men in an Oral PrEP Adherence Trial. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A23-4. PMID: 25357645.
    View in: PubMed
  69. Chan BT, Weiser SD, Boum Y, Siedner MJ, Mocello AR, Haberer JE, Hunt PW, Martin JN, Mayer KH, Bangsberg DR, Tsai AC. Persistent HIV-related Stigma in Rural Uganda during a Period of Increasing HIV Incidence. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A259. PMID: 25357728.
    View in: PubMed
  70. Psaros C, Haberer JE, Katabira E, Ronald A, Tumwesigye E, Campbell JD, Wangisi J, Mugwanya K, Kintu A, Enyakoit M, Thomas KK, Donnell D, Krows M, Kidoguchi L, Ware N, Baeten JM, Celum C, Bangsberg DR, Safren SA. An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):522-9. PMID: 24853311; PMCID: PMC4191829.
  71. Lankowski AJ, Tsai AC, Kanyesigye M, Bwana M, Haberer JE, Wenger M, Martin JN, Bangsberg DR, Hunt PW, Siedner MJ. Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy. PLoS Negl Trop Dis. 2014 Aug; 8(8):e3036. PMID: 25101890; PMCID: PMC4125278.
  72. Takada S, Weiser SD, Kumbakumba E, Muzoora C, Martin JN, Hunt PW, Haberer JE, Kawuma A, Bangsberg DR, Tsai AC. The dynamic relationship between social support and HIV-related stigma in rural Uganda. Ann Behav Med. 2014 Aug; 48(1):26-37. PMID: 24500077; PMCID: PMC4104218.
  73. McMahon JM, Myers JE, Kurth AE, Cohen SE, Mannheimer SB, Simmons J, Pouget ER, Trabold N, Haberer JE. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges. AIDS Patient Care STDS. 2014 Sep; 28(9):462-74. PMID: 25045996; PMCID: PMC4135325.
  74. Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, Mujugira A, Mugo N, Ndase P, Hendrix C, Celum C. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr. 2014 Jul 01; 66(3):340-8. PMID: 24784763; PMCID: PMC4059553.
  75. Kruse GR, Bangsberg DR, Hahn JA, Haberer JE, Hunt PW, Muzoora C, Bennett JP, Martin JN, Rigotti NA. Tobacco use among adults initiating treatment for HIV infection in rural Uganda. AIDS Behav. 2014 Jul; 18(7):1381-9. PMID: 24638166; PMCID: PMC4294428.
  76. Venkataramani AS, Thirumurthy H, Haberer JE, Ii YB, Siedner MJ, Kembabazi A, Hunt PW, Martin JN, Bangsberg DR, Tsai AC. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda. AIDS. 2014 May 15; 28(8):1221-6. PMID: 24406678; PMCID: PMC4092056.
  77. Machtinger EL, Lavin SM, Hilliard S, Jones R, Haberer JE, Capito K, Dawson-Rose C. An expressive therapy group disclosure intervention for women living with HIV improves social support, self-efficacy, and the safety and quality of relationships: a qualitative analysis. J Assoc Nurses AIDS Care. 2015 Mar-Apr; 26(2):187-98. PMID: 25027284.
    View in: PubMed
  78. Martinez P, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, Huang Y, Haberer JE, Martin JN, Bangsberg DR, Hunt PW. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. J Acquir Immune Defic Syndr. 2014 Apr 01; 65(4):456-62. PMID: 24220289; PMCID: PMC3943704.
  79. Kiwanuka J, Mulogo E, Haberer JE. Caregiver perceptions and motivation for disclosing or concealing the diagnosis of HIV infection to children receiving HIV care in Mbarara, Uganda: a qualitative study. PLoS One. 2014; 9(3):e93276. PMID: 24667407; PMCID: PMC3965550.
  80. Byakwaga H, Boum Y, Huang Y, Muzoora C, Kembabazi A, Weiser SD, Bennett J, Cao H, Haberer JE, Deeks SG, Bangsberg DR, McCune JM, Martin JN, Hunt PW. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy. J Infect Dis. 2014 Aug 01; 210(3):383-91. PMID: 24585899; PMCID: PMC4148610.
  81. Siedner MJ, Musinguzi N, Tsai AC, Muzoora C, Kembabazi A, Weiser SD, Bennett J, Hunt PW, Martin JN, Haberer JE, Bangsberg DR. Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda. AIDS. 2014 Jan 14; 28(2):267-71. PMID: 24361683; PMCID: PMC4038415.
  82. Tsai AC, Bangsberg DR, Kegeles SM, Katz IT, Haberer JE, Muzoora C, Kumbakumba E, Hunt PW, Martin JN, Weiser SD. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013 Dec; 46(3):285-94. PMID: 23690283; PMCID: PMC3795853.
  83. Tsai AC, Bangsberg DR, Bwana M, Haberer JE, Frongillo EA, Muzoora C, Kumbakumba E, Hunt PW, Martin JN, Weiser SD. How does antiretroviral treatment attenuate the stigma of HIV? Evidence from a cohort study in rural Uganda. AIDS Behav. 2013 Oct; 17(8):2725-31. PMID: 23670710; PMCID: PMC3773278.
  84. Matthews LT, Kaida A, Kanters S, Byakwagamd H, Mocello AR, Muzoora C, Kembabazi A, Haberer JE, Martin JN, Bangsberg DR, Hunt PW. HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods. AIDS. 2013 Oct; 27 Suppl 1:S105-12. PMID: 24088676; PMCID: PMC4142689.
  85. Kibengo FM, Ruzagira E, Katende D, Bwanika AN, Bahemuka U, Haberer JE, Bangsberg DR, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Kamali A, Priddy FH. Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial. PLoS One. 2013; 8(9):e74314. PMID: 24086333; PMCID: PMC3784443.
  86. Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, Tumwesigye E, Psaros C, Safren SA, Ware NC, Thomas KK, Donnell D, Krows M, Kidoguchi L, Celum C, Bangsberg DR. Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Med. 2013; 10(9):e1001511. PMID: 24058300; PMCID: PMC3769210.
  87. Haberer JE, Kiwanuka J, Nansera D, Muzoora C, Hunt PW, So J, O'Donnell M, Siedner M, Martin JN, Bangsberg DR. Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda. AIDS. 2013 Aug 24; 27(13):2166-8. PMID: 23751260; PMCID: PMC3868644.
  88. Kembabazi A, Bajunirwe F, Hunt PW, Martin JN, Muzoora C, Haberer JE, Bangsberg DR, Siedner MJ. Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern Uganda. PLoS One. 2013; 8(7):e69634. PMID: 23894514; PMCID: PMC3716596.
  89. Bachman Desilva M, Gifford AL, Keyi X, Li Z, Feng C, Brooks M, Harrold M, Yueying H, Gill CJ, Wubin X, Vian T, Haberer J, Bangsberg D, Sabin L. Feasibility and Acceptability of a Real-Time Adherence Device among HIV-Positive IDU Patients in China. AIDS Res Treat. 2013; 2013:957862. PMID: 23956851; PMCID: PMC3730150.
  90. Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, Kanungi J, Singh S, Haberer J, Priddy F, Sanders EJ. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013 Jul; 17(6):2162-72. PMID: 23080358; PMCID: PMC3690654.
  91. Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: where have we been and where are we going? J Acquir Immune Defic Syndr. 2013 Jul; 63 Suppl 2:S122-9. PMID: 23764623; PMCID: PMC3710117.
  92. Siedner MJ, Lankowski A, Tsai AC, Muzoora C, Martin JN, Hunt PW, Haberer JE, Bangsberg DR. GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda. AIDS. 2013 Jun 01; 27(9):1503-8. PMID: 23435294; PMCID: PMC3745818.
  93. Chaiyachati KH, Loveday M, Lorenz S, Lesh N, Larkan LM, Cinti S, Friedland GH, Haberer JE. A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment program. PLoS One. 2013; 8(5):e64662. PMID: 23724075; PMCID: PMC3665589.
  94. Kaida A, Matthews LT, Kanters S, Kabakyenga J, Muzoora C, Mocello AR, Martin JN, Hunt P, Haberer J, Hogg RS, Bangsberg DR. Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda. PLoS One. 2013; 8(5):e63411. PMID: 23704906; PMCID: PMC3660357.
  95. Hofer CB, Harris DR, Saavedra MC, Haberer JE, Romeiro J, Mussi-Pinhata MM, Stankievich E, Gomes IM, Kreitchmann R, Read JS. Adherence to antiretroviral prophylaxis during early infancy in Latin America. Braz J Infect Dis. 2013 Jul-Aug; 17(4):495-6. PMID: 23680065; PMCID: PMC4908580.
  96. Haberer JE, Trabin T, Klinkman M. Furthering the reliable and valid measurement of mental health screening, diagnoses, treatment and outcomes through health information technology. Gen Hosp Psychiatry. 2013 Jul-Aug; 35(4):349-53. PMID: 23628162; PMCID: PMC3692579.
  97. Baylor A, Muzoora C, Bwana M, Kembabazi A, Haberer JE, Matthews LT, Tsai AC, Hunt PW, Martin JN, Bangsberg DR. Dissemination of research findings to research participants living with HIV in rural Uganda: challenges and rewards. PLoS Med. 2013; 10(3):e1001397. PMID: 23472055; PMCID: PMC3589331.
  98. Adakun SA, Siedner MJ, Muzoora C, Haberer JE, Tsai AC, Hunt PW, Martin JN, Bangsberg DR. Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda. J Acquir Immune Defic Syndr. 2013 Mar 01; 62(3):317-21. PMID: 23242160; PMCID: PMC3696032.
  99. Bangsberg DR, Haberer JE. Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on "Managed problem solving for antiretroviral therapy adherence". JAMA Intern Med. 2013 Feb 25; 173(4):306-7. PMID: 23358810; PMCID: PMC4023478.
  100. Horwitz RH, Tsai AC, Maling S, Bajunirwe F, Haberer JE, Emenyonu N, Muzoora C, Hunt PW, Martin JN, Bangsberg DR. No association found between traditional healer use and delayed antiretroviral initiation in rural Uganda. AIDS Behav. 2013 Jan; 17(1):260-5. PMID: 22246516; PMCID: PMC3718889.
  101. Machtinger EL, Haberer JE, Wilson TC, Weiss DS. Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. AIDS Behav. 2012 Nov; 16(8):2160-70. PMID: 22426597.
    View in: PubMed
  102. Machtinger EL, Wilson TC, Haberer JE, Weiss DS. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav. 2012 Nov; 16(8):2091-100. PMID: 22249954.
    View in: PubMed
  103. Siedner MJ, Lankowski A, Musinga D, Jackson J, Muzoora C, Hunt PW, Martin JN, Bangsberg DR, Haberer JE. Optimizing network connectivity for mobile health technologies in sub-Saharan Africa. PLoS One. 2012; 7(9):e45643. PMID: 23029155; PMCID: PMC3460947.
  104. Bärnighausen T, Chaiyachati K, Chimbindi N, Haberer J, Newell ML. Antiretroviral therapy requires life-long adherence - Authors' reply. Lancet Infect Dis. 2012 Sep; 12(9):662. PMID: 22917100.
    View in: PubMed
  105. Siedner MJ, Tsai AC, Dworkin S, Mukiibi NF, Emenyonu NI, Hunt PW, Haberer JE, Martin JN, Bangsberg DR, Weiser SD. Sexual relationship power and malnutrition among HIV-positive women in rural Uganda. AIDS Behav. 2012 Aug; 16(6):1542-8. PMID: 22382629; PMCID: PMC3439197.
  106. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kakia A, Odoyo J, Mucunguzi A, Nakku-Joloba E, Twesigye R, Ngure K, Apaka C, Tamooh H, Gabona F, Mujugira A, Panteleeff D, Thomas KK, Kidoguchi L, Krows M, Revall J, Morrison S, Haugen H, Emmanuel-Ogier M, Ondrejcek L, Coombs RW, Frenkel L, Hendrix C, Bumpus NN, Bangsberg D, Haberer JE, Stevens WS, Lingappa JR, Celum C. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012 Aug 02; 367(5):399-410. PMID: 22784037; PMCID: PMC3770474.
  107. Siedner MJ, Lankowski A, Haberer JE, Kembabazi A, Emenyonu N, Tsai AC, Muzoora C, Geng E, Martin JN, Bangsberg DR. Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One. 2012; 7(6):e39894. PMID: 22761924; PMCID: PMC3383698.
  108. Siedner MJ, Haberer JE, Bwana MB, Ware NC, Bangsberg DR. High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study. BMC Med Inform Decis Mak. 2012 Jun 21; 12:56. PMID: 22720901; PMCID: PMC3470938.
  109. Kreitchmann R, Harris DR, Kakehasi F, Haberer JE, Cahn P, Losso M, Teles E, Pilotto JH, Hofer CB, Read JS. Antiretroviral adherence during pregnancy and postpartum in Latin America. AIDS Patient Care STDS. 2012 Aug; 26(8):486-95. PMID: 22663185; PMCID: PMC3462409.
  110. Haberer JE, Kiwanuka J, Nansera D, Ragland K, Mellins C, Bangsberg DR. Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children. PLoS One. 2012; 7(5):e36737. PMID: 22590600; PMCID: PMC3348916.
  111. van der Straten A, Van Damme L, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. AIDS. 2012 Apr 24; 26(7):F13-9. PMID: 22333749.
    View in: PubMed
  112. Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, Safren S, Tumwesigye E, Celum CL, Bangsberg DR. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. J Acquir Immune Defic Syndr. 2012 Apr 15; 59(5):463-8. PMID: 22267018; PMCID: PMC3826169.
  113. Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Priddy FH. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS One. 2012; 7(4):e33103. PMID: 22511916; PMCID: PMC3325227.
  114. Haberer JE, Robbins GK, Ybarra M, Monk A, Ragland K, Weiser SD, Johnson MO, Bangsberg DR. Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable. AIDS Behav. 2012 Feb; 16(2):375-82. PMID: 21448728; PMCID: PMC3193561.
  115. Bärnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis. 2011 Dec; 11(12):942-51. PMID: 22030332; PMCID: PMC4250825.
  116. Haberer JE, Cook A, Walker AS, Ngambi M, Ferrier A, Mulenga V, Kityo C, Thomason M, Kabamba D, Chintu C, Gibb DM, Bangsberg DR. Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS One. 2011 Apr 21; 6(4):e18505. PMID: 21533031; PMCID: PMC3080873.
  117. Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, MacKeen L, Haberer J, Kimaiyo S, Sidle J, Ngare D, Bangsberg DR. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011 Mar 27; 25(6):825-34. PMID: 21252632; PMCID: PMC3718389.
  118. Haberer JE, Kiwanuka J, Nansera D, Wilson IB, Bangsberg DR. Challenges in using mobile phones for collection of antiretroviral therapy adherence data in a resource-limited setting. AIDS Behav. 2010 Dec; 14(6):1294-301. PMID: 20532605; PMCID: PMC2975780.
  119. Haberer JE, Kahane J, Kigozi I, Emenyonu N, Hunt P, Martin J, Bangsberg DR. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010 Dec; 14(6):1340-6. PMID: 20809380; PMCID: PMC2974938.
  120. Katz IT, Ware NC, Gray G, Haberer JE, Mellins CA, Bangsberg DR. Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence. Sex Health. 2010 Sep; 7(3):279-86. PMID: 20719215; PMCID: PMC3141556.
  121. Haberer J, Mellins C. Pediatric adherence to HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2009 Nov; 6(4):194-200. PMID: 19849962; PMCID: PMC2967363.
  122. Zhang F, Haberer J, Wei H, Wang N, Chu A, Zhao Y, Zhao H. Drug resistance in the Chinese National Pediatric Highly Active Antiretroviral Therapy Cohort: implications for paediatric treatment in the developing world. Int J STD AIDS. 2009 Jun; 20(6):406-9. PMID: 19451326.
    View in: PubMed
  123. Zhang F, Haberer JE, Zhao Y, Dou Z, Zhao H, He Y, Cao GH. Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes. J Acquir Immune Defic Syndr. 2007 Dec 15; 46(5):594-8. PMID: 18043313.
    View in: PubMed
  124. Zhang F, Haberer JE, Wang Y, Zhao Y, Ma Y, Zhao D, Yu L, Goosby EP. The Chinese free antiretroviral treatment program: challenges and responses. AIDS. 2007 Dec; 21 Suppl 8:S143-8. PMID: 18172383.
    View in: PubMed
  125. Zhang F, Au MC, Bouey PD, Zhao Y, Huang ZJ, Dou Z, Li Z, Haberer J, Chen RY, Yu L. The diagnosis and treatment of HIV-infected children in China: challenges and opportunities. J Acquir Immune Defic Syndr. 2007 Apr 01; 44(4):429-34. PMID: 17224849.
    View in: PubMed
  126. Zhang FJ, Maria A, Haberer J, Zhao Y. Overview of HIV drug resistance and its implications for China. Chin Med J (Engl). 2006 Dec 05; 119(23):1999-2004. PMID: 17199945.
    View in: PubMed
  127. Haberer JE, Garrett B, Baker LC. Does Medicaid managed care affect access to care for the uninsured? Health Aff (Millwood). 2005 Jul-Aug; 24(4):1095-105. PMID: 16012150.
    View in: PubMed
  128. Matthew R, Banjevic M, Chan AS, Myers L, Wolkowicz R, Haberer J, Singer J. Use of the l1 norm for selection of sparse parameter sets that accurately predict drug response phenotype from viral genetic sequences. AMIA Annu Symp Proc. 2005; 505-9. PMID: 16779091; PMCID: PMC1560612.
  129. Haberer J, Trivedi NN, Kohlwes J, Tierney L. Clinical problem-solving. A gut feeling. N Engl J Med. 2003 Jul 03; 349(1):73-8. PMID: 12840095.
    View in: PubMed
  130. Haberer JE, Ix JH, Tierney LM. Clinical problem-solving. One foot away. N Engl J Med. 2002 May 02; 346(18):1394-7. PMID: 11986414.
    View in: PubMed
  131. Haberer JE, Da-Cruz AM, Soong L, Oliveira-Neto MP, Rivas L, McMahon-Pratt D, Coutinho SG. Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis. Infect Immun. 1998 Jul; 66(7):3100-5. PMID: 9632572; PMCID: PMC108319.
  132. Martinez P, Haberer JP, Hannhart B, Saunier C, Laxenaire MC. [Comparative evaluation of 13 pulse oximeters]. Ann Fr Anesth Reanim. 1989; 8 Suppl:R225. PMID: 2604184.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Haberer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_